Beeshman S Nandakumar1,2, Joanna E Fardell3,4, Claire E Wakefield1,2, Christina Signorelli1,2, Jordana K McLoone1,2, Jane Skeen5, Ann M Maguire6,7,8, Richard J Cohn1,2. 1. Discipline of Pediatrics, School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia. 2. Kids Cancer Centre, Sydney Children's Hospital (SCH), Randwick, NSW, Australia. 3. Discipline of Pediatrics, School of Women's and Children's Health, UNSW Sydney, Sydney, NSW, Australia. j.fardell@unsw.edu.au. 4. Kids Cancer Centre, Sydney Children's Hospital (SCH), Randwick, NSW, Australia. j.fardell@unsw.edu.au. 5. Starship Blood and Cancer Centre, Starship Children's Hospital, Auckland, 1124, New Zealand. 6. Discipline of Child and Adolescent Health, The University of Sydney, Sydney, New South Wales, Australia. 7. Long Term Follow Up Clinic, Department of Oncology, The Children's Hospital at Westmead, Sydney, New South Wales, Australia. 8. Institute of Endocrinology and Diabetes, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Abstract
PURPOSE: Survivors of pediatric cancer are prone to late effects which require ongoing medical care. Young adult survivors often transition from specialist pediatric care to adult-oriented or community-based healthcare. This study aims to describe the attitudes and experiences of survivors and their parents towards transition barriers and enablers. METHODS: Long-term survivors and parents (of survivors < 16 years) were recruited from 11 hospitals in Australia and New Zealand to participate in a semi-structured telephone interview regarding their transition experiences. Transcribed interviews were coded and content analysis was used to number participants within themes. RESULTS: Thirty-three participants were interviewed, of which 18 were survivors (mean age 26 years, SD = 6.3; mean time since treatment completion 13.3 years, SD = 6.1) and 15 were parents (mean survivor age 15 years, SD = 1.9; mean time since treatment completion 8.4 years, SD = 2.8). Participants described their transition attitudes as positive (55%), neutral (15%), or negative (30%). Key barriers to transition included dependence on pediatric healthcare providers, less confidence in primary care physicians (PCPs), inadequate communication, and cognitive difficulty. Enablers included confidence in and proximity to physicians, good communication, information, independence, and age. CONCLUSIONS: Many survivors face barriers to their transition out of pediatric care. Early introduction to transition, greater collaboration between healthcare professionals, and better information provision to survivors may improve the transition process. Future research of survivors' experience of barriers/enablers to transition is needed. Development of interventions, such as those that address self-management skills, is required to facilitate transition and encourage long-term engagement.
PURPOSE: Survivors of pediatric cancer are prone to late effects which require ongoing medical care. Young adult survivors often transition from specialist pediatric care to adult-oriented or community-based healthcare. This study aims to describe the attitudes and experiences of survivors and their parents towards transition barriers and enablers. METHODS: Long-term survivors and parents (of survivors < 16 years) were recruited from 11 hospitals in Australia and New Zealand to participate in a semi-structured telephone interview regarding their transition experiences. Transcribed interviews were coded and content analysis was used to number participants within themes. RESULTS: Thirty-three participants were interviewed, of which 18 were survivors (mean age 26 years, SD = 6.3; mean time since treatment completion 13.3 years, SD = 6.1) and 15 were parents (mean survivor age 15 years, SD = 1.9; mean time since treatment completion 8.4 years, SD = 2.8). Participants described their transition attitudes as positive (55%), neutral (15%), or negative (30%). Key barriers to transition included dependence on pediatric healthcare providers, less confidence in primary care physicians (PCPs), inadequate communication, and cognitive difficulty. Enablers included confidence in and proximity to physicians, good communication, information, independence, and age. CONCLUSIONS: Many survivors face barriers to their transition out of pediatric care. Early introduction to transition, greater collaboration between healthcare professionals, and better information provision to survivors may improve the transition process. Future research of survivors' experience of barriers/enablers to transition is needed. Development of interventions, such as those that address self-management skills, is required to facilitate transition and encourage long-term engagement.
Authors: Judith E Lupatsch; Laura Wengenroth; Corina S Rueegg; Oliver Teuffel; Fabienne Gumy-Pause; Claudia E Kuehni; Gisela Michel Journal: Pediatr Blood Cancer Date: 2015-09-23 Impact factor: 3.167
Authors: Janine Vetsch; Corina S Rueegg; Micòl E Gianinazzi; Eva Bergsträsser; Nicolas X von der Weid; Gisela Michel Journal: Pediatr Blood Cancer Date: 2015-02-07 Impact factor: 3.167
Authors: Lisa A Schwartz; Lauren C Daniel; Lauren D Brumley; Lamia P Barakat; Kimberly M Wesley; Lisa K Tuchman Journal: J Pediatr Psychol Date: 2014-06-01
Authors: Iqra A Syed; Paul C Nathan; Ronald Barr; Zahava R S Rosenberg-Yunger; Norma M D'Agostino; Anne F Klassen Journal: J Cancer Surviv Date: 2016-01-22 Impact factor: 4.442
Authors: Paul C Nathan; Mark L Greenberg; Kirsten K Ness; Melissa M Hudson; Ann C Mertens; Martin C Mahoney; James G Gurney; Sarah S Donaldson; Wendy M Leisenring; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2008-09-20 Impact factor: 50.717
Authors: Christina Signorelli; Claire E Wakefield; Joanna E Fardell; Tali Foreman; Karen A Johnston; Jon Emery; Elysia Thornton-Benko; Afaf Girgis; Hanne C Lie; Richard J Cohn Journal: Oncologist Date: 2018-08-31
Authors: Maria Otth; Sibylle Denzler; Christa Koenig; Henrik Koehler; Katrin Scheinemann Journal: J Cancer Surviv Date: 2020-07-16 Impact factor: 4.442
Authors: Karim Thomas Sadak; Milki T Gemeda; Michelle Grafelman; Joseph P Neglia; David R Freyer; Eileen Harwood; Jude Mikal Journal: BMC Cancer Date: 2020-09-21 Impact factor: 4.430